Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported its third quarter 2025 earnings results today.
Sales increased 7.2% year-over-year to $39 billion. Sales were up 6.9% on a constant currency basis. The top line results reflected sales growth in the US Retail Pharmacy and International segments.
Net loss was $175 million, or $0.20 per share, compared to net earnings of $344 million, or $0.40 per share, last year. Adjusted EPS was $0.38, down 39.6% on a constant currency basis.
US Retail Pharmacy segment sales were $30.7 billion, up 7.8% from the year-ago quarter.
International segment sales were $6.2 billion, up 7.8% YoY.
US Healthcare segment sales were $2.1 billion, slightly down from last year.
Given its pending acquisition by Sycamore Partners, WBA previously withdrew its guidance for fiscal year 2025.
